-
Pharmacological Testing of Nurr1 Agonists in Pre-clinical Models of Parkinson's Disease
… Björklund (Sweden). The Isacson laboratory will use a “multiple hit” model in which DA neuronal loss in the … of human wild type alpha-synuclein in the nigrostriatal system induces progressive loss of DA neurons that … degeneration in two preclinical models of PD based on a “multiple hit” pre-clinical model of inflammation and …
-
Measuring Parkinson’s Protein throughout Body
March 16, 2016
… Today, The Michael J. Fox Foundation (MJFF) launched the Systemic Synuclein Sampling Study (S4) to further … research at the Institute for Neurodegenerative Disorders. “Multiple studies have demonstrated the significance of … biomarker, but none have measured alpha-synuclein levels in multiple biofluids and peripheral tissues in a single …
-
Screen for Novel Glucocerebrosidase-Interacting Parkinson's Genes
… characteristic Parkinson’s disease pathology in the nervous system, as well as for motor problems (such as difficulty … of when GBA leads to degeneration of neurons in the nervous system. We expect that our screen will identify novel genes … Parkinson’s disease. With this study we expect to identify multiple genes with previously unrecognized roles in …
-
Global Efforts & Resources in Parkinson’s Research
… Disease The study, a collaborative effort between multiple nonprofit partner organizations and industry … Parkinson's Disease is Moving Towards a Biological Staging System Much like Alzeihmer's and Huntington's, Parkinson‘s disease is moving towards a biologic staging system, with a potentially transformational impact on …
-
TGF-beta Signaling as Novel Therapeutic Treatment for Parkinson's Disease
… to Diagnosis/Treatment of Parkinson’s Disease: TGF-beta has multiple associations with Parkinson’s disease as well as the nigrostriatal system. However, no direct causal relationship has been …
-
A New Pharmaceutical Target for Mono and Add-on Therapy in Parkinson’s Disease
… Description: We have recently discovered multiple small molecules that are capable of inhibiting the … A novel medicine for PD not targeting the dopamine system of the brain could improve patient’s quality of life. …